Commission Implementing Decision (EU) 2024/734 of 27 February 2024 postponing the expiry date of the approval of brodifacoum, bromadiolone, chlorophacinone, coumatetralyl, difenacoum, difethialone and flocoumafen for use in biocidal products of product-type 14 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

The expiry date of the approval of brodifacoum set out in the Annex to Implementing Regulation (EU) 2017/1381, of bromadiolone set out in the Annex to Implementing Regulation (EU) 2017/1380, of chlorophacinone set out in the Annex to Implementing Regulation (EU) 2017/1377, of coumatetralyl set out in Annex to Implementing Regulation (EU) 2017/1378, of difenacoum set out in Annex to Implementing Regulation (EU) 2017/1379, of difethialone set out in Annex to Implementing Regulation (EU) 2017/1382, and of flocoumafen set out in Annex to Implementing Regulation (EU) 2017/1383, for use in biocidal products of product-type 14 is postponed to 31 December 2026.

This Decision shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.